Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ImmunoGen Inc (NASDAQ:IMGN)

1.85
Delayed Data
As of Dec 07
 -0.13 / -6.57%
Today’s Change
1.51
Today|||52-Week Range
14.10
-86.37%
Year-to-Date
No recent news for ImmunoGen Inc.

Today’s Trading

Previous close1.98
Today’s open1.94
Day’s range1.80 - 1.94
Volume901,850
Average volume (3 months)1,273,049
Market cap$172.9M
Dividend yield--
Data as of 12/07/2016

Growth & Valuation

Earnings growth (last year)-135.21%
Earnings growth (this year)-1.21%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-29.86%
P/E ratioNM
Price/Sales4.46
Price/Book--

Competitors

 Today’s
change
Today’s
% change
OSIROsiris Therapeutics ...-0.08-1.50%
CBMGCellular Biomedicine...+0.10+0.76%
CYADCelyad SA-1.08-5.25%
NVIVInVivo Therapeutics ...0.000.00%
Data as of 12/07/2016

Financials

Next reporting dateFebruary 3, 2017
EPS forecast (this quarter)-$0.38
Annual revenue (last year)$60.0M
Annual profit (last year)-$144.8M
Net profit margin-241.35%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark J. Enyedy
Chief Financial Officer &
Executive Vice President
David B. Johnston
Corporate headquarters
Waltham, Massachusetts

Forecasts


Search for Jobs